Introduction
TB
DISEASE PROGRESSION
According to the estimation by the World Health Organization (WHO), about a quarter of the world’s population was infected with The 2020 updated WHO guidelines recommended that individuals with a history of inactive TB or fibrotic lesions should not be a contraindication for preventive treatment, due to the increased risk of active disease progression [In addition, our previous studies have proved the efficacy of a six-week regimen (rifapentine plus isoniazid) as 69% in two years [